AUA 2019 Bladder Cancer - Results from #20

Viewing 21-36 of 36 articles

AUA 2019: Nephron-sparing Management of Low Grade UTUC with UGN-101 for Instillation: The Olympus Trial Experience

AUA 2019: Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer with Tamoxifen

AUA 2019: Automated Cystoscopic Detection of Bladder Cancer Using Deep-learning

AUA 2019: Is Gemcitabine the New Post-TUR Standard of Care?

AUA 2019: Budding Biotechnologies of Bladder Cancer

AUA 2019: ERAS vs. Robotics: Which Provides the Most Incremental Benefit? - ERAS

AUA 2019: Crowdsourcing: Transurethral Resection of Bladder Tumor

AUA 2019: Flexible Blue Light Cystoscopy with Hexaminolevulinate Provides Opportunity to Finalize Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer in the Outpatient Clinic: Results from a Nordic Registry

AUA 2019: Rationale for Post-Ureteroscopy Intravesical Chemotherapy for Upper Tract Urothelial Carcinoma

AUA 2019: Nadofaragene firadenovec (Adstiladrin®) — Late-Breaking Phase 2 Data for Patients with High-grade, BCG Refractory or Relapsed Non-muscle Invasive Bladder Cancer

AUA 2019: Chemoablation of Upper Tract Urothelial Carcinoma

AUA 2019: Tumor Board: Bladder Cancer

AUA 2019: Bladder Cancer Blue Light Cystoscopy with CYSVIEW®

AUA 2019: Radical Cystectomy Accessibility Challenges Associated with Hospital Volume

AUA 2019: Trends in Extended-Duration Postoperative Venous Thromboembolism Prophylaxis following Radical Cystectomy

AUA 2019: Prospective Implementation of a Non-Opioid Protocol for Patients Undergoing Robot-Assisted Radical Cystectomy

1
2